<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        12-5015-18
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ANASTROZOLE 1MG F.C.TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ANASTROZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        156.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LABORATORIOS CINFA SA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LABORATORIOS CINFA SA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            LABORATORIOS CINFA SA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L02BG03 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Anastrozole&nbsp; belongs to a group of medicines known as aromatase inhibitors. This means<br />that it interferes with some of the actions of aromatase, an enzyme in the body that reduces the<br />level of some female sex hormones such as oestrogens.<br />Anastrozole cinfa is used to treat breast cancer in postmenopausal women.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take anastrozole cinfa:<br /> If you are allergic (hypersensitive) to anastrozole or to any of the other ingredients of this<br />medicine.<br /> If you have not had the menopause.<br /> If you are pregnant.<br /> If you are breast-feeding.<br /> If you have a serious disease or disorder of the liver or kidneys.<br /> If you are using tamoxifen (see section 2, Taking other medicines).<br /> If you are using medicines containing oestrogens, for example hormone replacement therapy<br />(see section 2, Taking other medicines).<br />Do not take anastrozole cinfa in any of the situations described above. If you are unsure,<br />ask your doctor or pharmacist for advice before taking this medicine.<br />Anastrozole cinfa should not be given to children.<br />Take special care with anastrozole cinfa:<br />Before you take anastrozole, check with your doctor or pharmacist:<br /> If you have suffered, or are suffering, from any condition that affects the strength of your<br />bones (osteoporosis).<br /> If you have any liver or kidney problems.<br />If you are not sure whether any of the above applies to you, talk to your doctor or pharmacist<br />before taking anastrozole cinfa.<br />If you are admitted to hospital, tell the medical staff that you are taking this medicine.<br />Taking other medicines:<br />Tell your doctor or pharmacist if you are taking or have recently taken other medicines,<br />including non-prescription medicines.<br />Do not take anastrozole cinfa if you are already taking any of the following medicines:<br /> tamoxifen (a specific medicine used in breast cancer), as it may stop anastrozole cinfa<br />from working properly.<br /> medicines containing oestrogens, for example hormone replacement therapy (HRT).<br />If this applies to you, ask your doctor or pharmacist for advice.<br />Check with your doctor or pharmacist if you are taking the following:<br />&bull; A medicine known as an &ldquo;LHRH analog&rdquo;. This includes gonadorelin, buserelin, goserelin,<br />leuprorelin and triptorelin.<br />These medicines are used to treat breast cancer, some female (gynaecological) health conditions<br />and infertility.<br />Taking anastrozole cinfa with food and drink:<br />Anastrozole is not affected by food and drink.<br />Pregnancy and breast-feeding:<br />Ask your doctor or pharmacist for advice before using any medicine.<br />Do not take anastrozole cinfa if you are pregnant or breast-feeding.<br />Driving and using machines:<br />Anastrozole is not likely to affect your ability to drive or use any machinery or tools. However,<br />you may occasionally feel weak or drowsy, in which case you should ask your doctor or<br />pharmacist for advice.<br />Important information regarding some of the ingredients of anastrozole cinfa:<br />This medicine contains lactose. If your doctor has indicated that you suffer intolerance to certain<br />sugars, ask him/her before taking this medicine.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take anastrozole cinfa exactly as your doctor has told you. Check with your doctor or<br />pharmacist if you are not sure.<br />Anastrozole cinfa should not be given to children.<br />Taking anastrozole cinfa:<br />&bull; The normal dose is one tablet a day.<br />&bull; Try to take the tablet at the same time each day.<br />&bull; Swallow the tablet whole with water.<br />&bull; You can take this medicine before, during or after a meal.<br />Keep taking anastrozole for as long as your doctor tells you to as this is a long-term treatment<br />that you may need to take for several years.<br />If you take more anastrozole cinfa than you should:<br />If you have taken more anastrozole cinfa than you should, consult your doctor or pharmacist<br />immediately.<br />In case of overdose or accidental ingestion, contact the Toxicology Information Service<br />(telephone: 91 562 04 20).<br />If you forget to take anastrozole cinfa:<br />Do not take a double dose to make up for a forgotten dose. Miss this dose and take the<br />following tablet at the usual time.<br />If you stop taking anastrozole cinfa:<br />Do not stop taking the medicine unless your doctor tells you to.<br />If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, anastrozole cinfa can cause side effects, although not everybody gets them.<br />Severe allergic reactions:<br />If you experience any of the following situations, call an ambulance or visit your doctor<br />immediately as you may need urgent medical treatment:<br />- Swollen face, lips, tongue or throat, which may cause difficulties in swallowing or<br />breathing (rare, affect less than 1 person in every 1000).<br />- An extremely severe skin reaction with ulcers or blisters. This is known as<br />&ldquo;Stevens-Johnson syndrome&rdquo; (the frequency of this adverse effect is not known).<br />Effects on the liver (uncommon, affecting fewer than 1 out of every 100 people):<br />The symptoms may include:<br />- Yellowing of the skin or eyes, dark colour of urine, loss of appetite and general feeling<br />of malaise.<br />If this occurs, visit your doctor immediately as you may need a medical test or treatment.<br />Other possible side effects (not normally serious):<br />Very common (affecting more than 1 out of every 10 people):<br />- Hot flushes.<br />- Weakness.<br />- Joint pain or stiffness.<br />- Skin rash (may include a type of rash known as &ldquo;urticaria&rdquo; or &ldquo;wheals&rdquo;).<br />- Dizziness (nausea).<br />- Headache.<br />Common (affecting less than 1 out of every 10 people):<br />- Vaginal dryness.<br />- Vaginal bleeding (normally in the first weeks of treatment; if the bleeding continues,<br />talk to your doctor).<br />- Thinning of hair (hair loss).<br />- Diarrhoea.<br />- Loss of appetite.<br />- Increased levels of a fatty substance known as cholesterol in blood, which is detected<br />in a blood analysis.<br />- Vomiting.<br />- Drowsiness.<br />- Carpal tunnel syndrome (tingling, pain, coldness, weakness in regions of the hand).<br />- Changes in the blood tests that show how well your liver is working.<br />Uncommon (affecting less than 1 out of every 100 people):<br />- Trigger finger (a condition in which one of your fingers is stuck in a bent position).<br />Effects on your bones<br />- Anastrozole cinfa reduces the level of hormones known as oestrogens that are present in<br />your body. This can lower the mineral content of your bones, which may weaken them and<br />make fractures more likely. Your doctor will control these risks according to the treatment<br />guidelines for managing bone health in postmenopausal women. You should talk to your<br />doctor about the risks and treatment options.<br />If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,<br />please tell your doctor or pharmacist.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.<br />This medicine does not require any special storage conditions.<br />Do not use anastrozole cinfa after the expiry date stated on the container after &ldquo;EXP&rdquo;.<br />The expiry date refers to the last day of that month.<br />Medicines should not be disposed of via wastewater or household waste. Place the containers<br />and medicines you no longer need in the SIGRE point at the pharmacy. In case of doubt,<br />ask your pharmacist how to throw away medicines and containers you no longer need. These<br />measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is anastrozole. Each tablet contains 1 mg of anastrozole.<br />The other ingredients are:<br />- Tablet core: lactose monohydrate, anhydrous lactose, sodium carboxymethyl starch from<br />potato, microcrystalline cellulose (E460), anhydrous colloidal silica and magnesium stearate.<br />- Tablet coating: Hypromellose (E464), titanium dioxide (E171) and Macrogol 6000.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
anastrozole cinfa is presented in the form of white, cylindrical biconvex tablets. Each package
contains 28 or 100 (clinical pack) tablets.
Not all package sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><br />LABORATORIOS CINFA, S.A.<br />Olaz-Chipi, 10 &ndash; Pol&iacute;gono Areta<br />31620 Huarte-Pamplona (Navarre)<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was approved in Sep-2014
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي سنفاستروزول على مادة فعالة تُدعى أناستروزول. وينتمي إلى مجموعة من الأدوية تعرف بمثبطات الأروماتيز. يُستخدم اناستروزول لعلاج سرطان الثدي لدى النساء اللاتي تجاوزن سن انقطاع الطمث.</p><p dir="RTL">يعمل اناستروزول من خلال خفض مقدار هرمون الإستروجين الذي يفرزه الجسم. وذلك من خلال تثبيط إفراز مادة طبيعية (إنزيم) داخل الجسم تُدعى &quot;أروماتيز&quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناولي اناستروزول إذا:</p><p dir="RTL">? كان لديكٍ حساسية للأناستروزول أو أي من مكونات الدواء الأخرى (المدرجة في قسم 6).</p><p dir="RTL">?إ كنت حاملاً أو في فترة الرضاعة (انظري القسم بعنوان &quot;الحمل والرضاعة&quot;).</p><p dir="RTL">لا تتناولي اناستروزول إذا انطبقت أيٌ من هذه الحالات عليك. في حال عدم التأكد فاستشري طبيبك أو الصيدلي قبل تناول اناستروزول.</p><p dir="RTL">الاحتياطات والتحذيرات</p><p dir="RTL">تحدثي مع طبيبك أو الصيدلي أو الممرضة قبل تناول اناستروزول إذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">? كنت لا تزالين في مرحلة نزول الدورة الشهرية ولم تصلي إلى سن انقطاع الطمث.</p><p dir="RTL">? كنت تتناولين عقاراً يحتوي على تاموكسيفن أو أي عقاقير أخرى تحتوي على هرمون الإستروجين (انظري القسم بعنوان &quot;تفاعلات اناستروزول مع الأدوية الأخرى&quot;).</p><p dir="RTL">? أُصبت سابقاً بمرض يؤثر في قوة عظامك (هشاشة عظام).</p><p dir="RTL">? كنت تعانين مشكلات في الكبد أو الكُلى.</p><p dir="RTL">إذا لم تكوني متأكدة من انطباق هذه الحالات عليك فتحدثي مع طبيبك أو الصيدلي قبل تناول اناستروزول.</p><p dir="RTL">إذا دخلت المستشفى فأخبري الفريق الطبي أنك تتناولين اناستروزول.</p><p dir="RTL">التفاعلات مع الأدوية الأخرى</p><p dir="RTL">أخبري الطبيب أو الصيدلي إذا كنت تتناولين أي أدوية أخرى أو تناولتها مؤخراً. ويشمل ذلك الأدوية المتاحة دون وصفة طبية والأدوية المكونة من أعشاب. نظراً لإمكانية تأثير اناستروزول في آلية عمل بعض الأدوية، كذلك إمكانية تأثير أدوية أخرى في مفعول اناستروزول.</p><p dir="RTL">لا تتناولي اناستروزول إذا كنت تتناولين بالفعل أياً من الأدوية التالية:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية التي تستخدم لعلاج سرطان الثدي (مُعدلات مستقبلات هرمون الإستروجين الانتقائية)، مثل الأدوية التي تحتوي على تاموكسيفن. لأن هذه الأدوية قد تحول دون عمل اناستروزول بشكل صحيح</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحتوي على إستروجين كما في العلاج بالهورمونات البديلة (HRT). إذا كنت تخضعين لمثل هذا العلاج فاستشري طبيبك أو الصيدلي.</p><p dir="RTL">أخبري طبيبك أو الصيدلي إذا كنت تتناول الأدوية التالية:</p><p dir="RTL">?دواء يعرف باسم نظير الهرمون المطُلِق للهرمون الملوتن (LHRH). ويشمل جونادوريلين وبسيريلين وجوسيريلين وليوبروريلين وتريبتوريلين. تُستخدم هذه الادوية لعلاج سرطان الثدي وبعض الحالات المرضية لدى الإناث (طب النساء والتوليد)، والعقم</p><p dir="RTL">الحمل والإرضاع</p><p dir="RTL">لا تتناولي سينفاسروزول إذا كنتِ حاملاً أو خلال فترة الرضاعة. توقفي عن تناول سينفاسروزول إذا أصبحت حاملاً وتحدثي مع طبيبك.</p><p dir="RTL">استشيري طبيبك أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL">القيادة وتشغيل الآلات</p><p dir="RTL">من غير المحتمل أن يؤثر اناستروزول في قدرتك علي القيادة أو استعمال أي من الآلات أو الأدوات. بالرغم من ذلك، أحياناً قد يشعر البعض بالوهن أو النعاس أثناء تناول اناستروزول. إذا كنت تشعرين بهذه الأعراض فاستشري طبيبك أو الصيدلي.</p><p dir="RTL">يحتوى اناستروزول على اللاكتوز</p><p dir="RTL">يحتوي سينفاسترازول على اللاكتوز وهو أحد أنواع السكر. إذا أخبرك طبيبك أنك تعانين حساسية لبعض أنواع السكر فاستشري طبيبك قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناولي هذا الدواء دائماً حسب وصف الطبيب أو الصيدلي. استشيري طبيبك أو الصيدلي إذا لم تكوني متأكدة.</p><p dir="RTL">?الجرعة الموصى بها هي قرص واحد يومياً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">?حاولي تناول جرعتك اليومية في نفس الوقت من كل يوم.</p><p dir="RTL">?ابتلعي القرص بالكامل مع كوب من الماء.</p><p dir="RTL">?لا يهم تناول اناستروزول قبل أو أثناء أو بعد تناول الطعام.</p><p dir="RTL">تناولي اناستروزول طوال المدة التي يوصي بها طبيبك أو الصيدلي. فهو علاج طويل الأمد قد تحتاجين إلى تناوله لسنوات عديدة. استشري طبيبك أو الصيدلي إذا لم تكوني متأكدة.</p><p dir="RTL">الاستخدام من قبل الأطفال والمراهقين</p><p dir="RTL">لا يجب إعطاء اناستروزول للأطفال والمراهقين.</p><p dir="RTL">تناول جرعة زائدة من اناستروزول</p><p dir="RTL">إذا تناولت جرعة زائدة من اناستروزول فتحدثي مع الطبيب على الفور.</p><p dir="RTL">إذا نسيت تناول اناستروزول</p><p dir="RTL">إذا نسيت تناول إحدى الجرعات فتناولي الجرعة التالية في موعدها الطبيعي.</p><p dir="RTL">لا تتناولي جرعة مضاعفة (جرعتين في نفس الوقت) لتعويض الجرعة المنسية.</p><p dir="RTL">إذا توقفتِ عن تناول اناستروزول</p><p dir="RTL">لا تتوقفي عن تناول الأقراص حتى يخبرك الطبيب بذلك.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن طريقة استخدام هذا الدواء فاسألي طبيبك أو الصيدلي أو الممرضة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل كل الأدوية، قد يسبب هذا الدواء آثاراً جانبية، ولكنها لا تظهر بالضرورة على كل من يتناوله.</p><p dir="RTL">الآثار الجانبية الشديدة الشيوع (تؤثر في أكثر من شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاحمرار المفاجئ.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء (الغثيان)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في المفاصل أو تيبسها.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المفاصل.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالوهن.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هشاشة العظام.</p><p dir="RTL">الآثار الجانبية الشائعة (تؤثر في شخص إلى 10 أشخاص من كل 100 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات المادة الدهنية التي تعرف باسم الكوليسترول في الدم. يظهر ذلك في اختبار الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالنعاس.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة النفق الرسغي (شعور بالوخز، والألم والبرودة والضعف في أجزاء من اليد).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالدغدغة أو الوخز الخفيف أو التخدير وفقدان حاسة التذوق.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء (القيء).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير النسب المتعلقة بوظائف الكبد في فحوصات الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات الحساسية الحادة مثل تورم الوجه أو الشفتين أو اللسان.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام العظام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف المهبل.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف من المهبل (عادةً يحدث ذلك خلال الأسابيع الأولى من العلاج - في حال استمر النزيف تحدثي مع طبيبك).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في العضلات.</p><p dir="RTL">الآثار الجانبية غير الشائعة (تؤثر في شخص إلى 10 أشخاص من كل 1,000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير النسب المتعلقة بوظائف الكبد في بعض فحوصات الدم (إنزيم جاما-جي تي وبيليروبين).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشرى أو طفح القراص.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأصبع الزنادية (هي حالة يكون فيها أصبع الإبهام أو أي أصبع آخر من أصابع اليد في الوضع المنحني مثل وضع الأصبع على زناد البندقية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات الكالسيوم في الدم. في حال إصابتك بالغثيان والقيء والشعور بالعطش، يجب عليك إخبار طبيبك أو الصيدلي أو الممرضة قد تحتاجين إلى إجراء بعض فحوصات الدم.</p><p dir="RTL">الآثار الجانبية النادرة (تؤثر في شخص إلى 10 أشخاص من كل 10,000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب نادر للبشرة قد يشمل ظهور رقع أو بثرات حمراء.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي ناتج عن الحساسية المفرطة (قد ينتج عن أحد تفاعلات الحساسية أو تَفاعُلٌ تَأَقانِيّ).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية الصغيرة مما يسبب تغير لون الجلد إلى اللون الأحمر أو الأرجواني. قد تظهر أعراض شديدة الندرة كآلام في المفاصل والمعدة والكلية؛ وتعرف هذه الحالة باسم &quot;فرفرية هينوخ شونلاين&quot;.</p><p dir="RTL">الآثار الجانبية الشديدة الندرة (تؤثر في أقل من شخص واحد من كل 10,000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعل جلدي شديد مع ظهور قرح أو بثرات على البشرة. تُعرف هذه الحالة بمتلازمة ستيفنز جونسون.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات الحساسية (فرط الحساسية) مع تورم الحلق الذي قد ينتج عنه صعوبة في البلع أو التنفس. تُعرف هذه الحالة باسم الوذمة الوعائية.</p><p dir="RTL">في حال إصابتك بأي من الحالات السابقة اتصلي بسيارة الإسعاف أو استشري طبيبك على الفور - فقد تحتاجين إلى علاج طبي عاجل.</p><p dir="RTL">الآثار التي تصيب العظام</p><p dir="RTL">يعمل اناستروزول على خفض كمية هرمون الإستروجين في الجسم. الأمر الذي قد يؤدي إلى خفض المحتوى المعدني للعظام. قد تصبح عظامك أكثر وهناً وأكثر عرضة للكسر. سيقوم طبيبك بتدارك هذه المخاطر وفقاً لإرشادات العلاج الخاصة بالعناية بصحة العظام لدى النساء اللاتي بلغن سن انقطاع الطمث. يجب التحدث مع طبيبك حول هذه المخاطر والاختيارات العلاجية.</p><p dir="RTL">إذا تطور أي من هذه الآثار الجانبية لدرجة خطيرة، أو إذا لاحظتِ حدوث أي آثار جانبية غير مدرجة بهذه النشرة فأخبري الطبيب أو الصيدلي.</p><p dir="RTL">الإبلاغ عن ظهور آثار جانبية</p><p dir="RTL">إذا ظهرت عليك أي آثار جانبية فأخبري الطبيب أو الصيدلي أو الممرضة. ويشمل ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ في درجة حرارة لا تزيد على 30 &deg;م.</p><p dir="RTL">يحفظ هذا الدواء بعيداً عن متناول الأطفال. تُحفظ الأقراص في مكان آمن حيث لا يمكن للأطفال رؤيتها أو الوصول إليها. فقد تسبب هذه الأقراص ضرراً لهم.</p><p dir="RTL">لا يُستعمل هذا الدواء بعد انتهاء تاريخ الصلاحية الموضح على العلبة وشريط الأقراص. يشير تاريخ الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL">تُحفظ الأقراص في العلبة التي جاءت فيها.</p><p dir="RTL">ينبغي عدم التخلص من أي أدوية عن طريق مياه الصرف أو النفايات المنزلية. سلي الصيدلي عن طريقة التخلص من الأدوية التي لا تستعملينها. تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي اناستروزول على</p><p dir="RTL">المادة الفعالة هي الأناستروزول. يحتوي كل قرص مغلف على 1 ملجم أناستروزول.</p><p dir="RTL">أما المكونات الأخرى فهي:</p><p dir="RTL">- محتوى القرص من الداخل: مونوهيدرات اللاكتوز، واللاكتوز اللا مائي، وكاربوكسيميثيل الصوديوم النشا المستخرج من البطاطس، والسليلوز الدقيق البلورات (E-460)، والسيليكا الغروانية اللامائية وستيارات الماغنسيوم.</p><p dir="RTL">- محتوى القرص من الداخل: هايبروميلوز(E-464) وثنائي أكسيد التيتانيوم (E171) والماكروغول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشكل الصيدلي لدواء اناستروزول ومحتويات العلبة</p><p dir="RTL">يتوفر اناستروزول في شكل أقراص بيضاء أسطوانية محدبة الوجهين.</p><p dir="RTL">يتوفر اناستروزول في عبوة تحتوي على 28 قرصاً (في سبع شرائط مغلفة).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">مختبرات سينفا، ش.م.</p><p dir="RTL">شارع أولاز شيبي، 10 منطقة بوليغنو الصناعية</p><p dir="RTL">31620 أوارتي-بامبلونا (نافارا) - إسبانيا</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أجريت آخر مراجعة لهذه النشرة في سبتمبر 2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                anastrozole cinfa 1 mg film-coated tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 1 mg of anastrozole.
Excipients: each tablet contains 32 mg of lactose.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets (tablets).
White, cylindrical, biconvex film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment for advanced breast cancer in post-menopausal women. Its efficacy has not been<br />demonstrated in oestrogen receptor-negative patients except for those who have shown<br />a positive clinical response to tamoxifen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology:<br />Adults, including the elderly.<br />One 1 mg tablet once a day.<br />Paediatric population.<br />Its use in this population is not recommended due to the limited safety and efficacy data<br />(see sections 4.4 and 5.1).<br />Renal failure.<br />Dose adjustment is not recommended in patients with mild or moderate renal failure.<br />Hepatic failure.<br />Dose adjustment is not recommended in patients with mild hepatic failure.<br />In initial stages, the recommended duration of treatment is 5 years.<br />Method of administration:<br />Oral route.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Premenopausal women.
- Pregnant or breast-feeding women.
- Severe renal failure (creatinine clearance < 20 mL/min)
- Moderate or severe hepatic failure.
- Hypersensitivity to anastrozole or to any of the excipients.
Co-administration of anastrozole with oestrogen-containing treatments should be avoided
as this may reduce its pharmacological action.
Concomitant treatment with tamoxifen (see section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Administration of anastrozole in the paediatric population is not recommended as its safety<br />and efficacy in this group of patients has not been established (see section 5.1).<br />This medicinal product should not be administered jointly with growth hormone treatment in<br />boys with a deficiency in this hormone. In the pivotal clinical trial, efficacy was not<br />demonstrated and safety was not established (see section 5.1). Anastrozole should not be used<br />together with growth hormone treatment in girls with a deficiency in this hormone as anastrozole<br />reduces oestradiol levels. No long-term safety data in children and adolescents are available.<br />Menopause should be confirmed biochemically in patients for whom doubts regarding their<br />hormonal status exist.<br />Data supporting the safe use of anastrozole in patients with moderate or severe hepatic impairment<br />or in patients with severe renal impairment (creatinine clearance &lt; 20 mL/min) are not available.<br />Bone density in women with osteoporosis or at risk of suffering from it should be assessed by<br />bone densimetry, for example using a DEXA scanner, in a protocolised manner at the onset of<br />treatment and at regular intervals subsequently. Osteoporosis treatment or prophylaxis should<br />be initiated when required and monitored carefully.<br />There are no data regarding the use of anastrozole with LHRH analogs. This combination<br />should not be used outside the scope of clinical trials.<br />As anastrozole reduces circulating oestrogen levels, it may provoke a reduction in bone<br />mineral density and therefore an increased risk of fracture. The use of bisphosphonates may<br />inhibit the additional bone mineral loss provoked by anastrozole in postmenopausal women<br />and should therefore be considered.<br />Warnings on excipients:<br />This medicine contains lactose. Patients with a hereditary galactose intolerance, Lapp lactase<br />deficiency (deficiency observed in some towns in Lapland) or glucose-galactose<br />malabsorption should not take this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical interaction studies with antipyrine and cimetidine suggest that co-administration of<br />anastrozole with other drugs is unlikely to produce clinically significant drug interactions<br />mediated by cytochrome P450.<br />A review of the clinical safety trials database found no evidence for clinically significant<br />interaction in patents treated simultaneously with anastrozole and drugs prescribed normally.<br />There were no clinically significant interactions with bisphosphonates (see section 5.1).<br />Oestrogen-based therapies should not be administered jointly with anastrozole as they may<br />cancel out its pharmacological effect.<br />Tamoxifen should not be co-administered with anastrozole as this may reduce its pharmacological action (see section 4.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Anastrozole is contraindicated during pregnancy.<br />Breast-feeding<br />Anastrozole is contraindicated in breast-feeding women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The influence of anastrozole on the ability to drive and operate machinery is negligible.<br />However, asthenia and somnolence have been reported during treatment with anastrozole,<br />therefore caution should be observed when driving or operating machinery while such<br />symptoms persist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Unless otherwise specified, the following frequency categories have been calculated on the basis<br />of the number of adverse events reported in a large phase-III trial performed in 9366<br />postmenopausal women with operable breast cancer receiving treatment for 5 years (ATAC study)<br />Frequency Classification by system<br />organ class<br />Adverse Reaction<br />Very common (&ge; 1/10) Vascular disorders Hot flushes, usually mild or<br />moderate in nature.<br />General disorders Asthenia, usually mild or<br />moderate in nature.<br />Musculoskeletal and connective<br />tissue disorders<br />Joint pain/stiffness, usually<br />mild or moderate in nature.<br />Nervous system disorders Headache, usually mild or<br />moderate in nature.<br />Gastrointestinal disorders Nausea, usually mild or<br />moderate in nature.<br />Skin and subcutaneous tissue<br />disorders<br />Skin rash, usually mild or<br />moderate in nature.<br />Common<br />(&ge; 1/100 to &lt; 1/10)<br />Skin and subcutaneous tissue<br />disorders<br />Hair thinning (alopecia), usually<br />mild or moderate in nature.<br />Allergic reactions.<br />Gastrointestinal disorders Diarrhoea, usually mild or<br />moderate in nature.<br />Vomiting, usually mild or<br />moderate in nature.<br />Nervous system disorders Drowsiness, usually mild or<br />moderate in nature.<br />Carpal tunnel syndrome.<br />Hepatobiliary disorders Increased alkaline phosphatase,<br />alanine aminotransferase,<br />aspartate aminotransferase.<br />Reproductive system and breast<br />disorders<br />Vaginal dryness, usually mild<br />or moderate in nature.<br />Vaginal bleeding, usually mild<br />or moderate in nature*.<br />Metabolism and nutrition<br />disorders<br />Anorexia, usually mild in nature.<br />Hypercholesterolaemia, usually<br />mild or moderate in nature.<br />Uncommon<br />(&ge;1/1000 to &lt;1/100)<br />Hepatobiliary disorders Increased gamma-GT and<br />bilirubin.<br />Hepatitis.<br />Skin and subcutaneous tissue<br />disorders<br />Urticaria<br />Musculoskeletal and connective<br />tissue disorders<br />Trigger finger<br />Rare<br />(&ge;1/10,000 to &lt;1/1000)<br />Skin and subcutaneous tissue<br />disorders<br />Erythema multiforme.<br />Anaphylactic type reaction.<br />Frequency not known Skin and subcutaneous tissue<br />disorders<br />Stevens-Johnson<br />syndrome**.<br />Angioedema**.<br />* Vaginal bleeding has been reported commonly, mainly in patients with advanced breast<br />cancer during the first few weeks after changing from existing hormonal therapy to treatment<br />with anastrozole.. If bleeding persists, further evaluation should be considered.<br />** Cannot be estimated from the available information.<br />As anastrozole reduces circulating oestrogen levels, it may provoke a reduction in bone<br />mineral density and therefore an increased risk of fracture in some patients (see section 4.4).<br />The table below presents the frequency of pre-specified adverse events in the ATAC study,<br />irrespective of causality, reported in patients receiving trial therapy and up to 14 days after<br />cessation of trial therapy.<br />Undesirable effects Anastrazole<br />(N=3092)<br />Tamoxifen<br />(N=3094)<br />Hot flushes 1104 (35.7%) 1264 (40.9%)<br />Joint pain/stiffness 1100 (35.6%) 911 (29.4%)<br />Mood swings 597 (19.3%) 554 (17.9%)<br />Fatigue/asthenia 575 (18.6%) 544 (17.6%)<br />Nausea and vomiting 393 (12.7%) 384 (12.4%)<br />Fractures 315 (10.2%) 209 (6.8%)<br />Spinal, hip or wrist/Colles fractures 133 (4.3%) 91 (2.9%)<br />- Wrist/Colles fractures 67 (2.2%) 50 (1.6%)<br />- Spinal fractures 43 (1.4%) 22 (0.7%)<br />- Hip fractures 28 (0.9%) 26 (0.8%)<br />Cataracts 182 (5.9%) 213 (6.9%)<br />Vaginal bleeding 167 (5.4%) 317 (10.2%)<br />Ischaemic cardiovascular disease 127 (4.1%) 104 (3.4%)<br />- Angina pectoris 71 (2.3%) 51 (1.6%)<br />- Myocardial infarction 37 (1.2%) 34 (1.1%)<br />- Coronary artery disorder 25 (0.8%) 23 (0.7%)<br />- Myocardial ischaemia 22 (0.7%) 14 (0.5%)<br />Vaginal discharge 109 (3.5%) 408 (13.2%)<br />Any venous thromboembolic event 87 (2.8%) 140 (4.5%)<br />- Deep venous thromboembolic events,<br />including pulmonary embolism<br />48 (1.6%) 74 (2.4%)<br />Ischaemic cerebrovascular events 62 (2.0%) 88 (2.8%)<br />Endometrial cancer 4 (0.2%) 13 (0.6%)<br />Fracture rates of 22 per 1000 patient-years and 15 per 1000 patient-years were observed for<br />the anastrozole and tamoxifen groups, respectively, after a median follow-up of 68 months.<br />The observed fracture rate for anastrozole is similar to the range reported in age-matched<br />postmenopausal populations. It has not been determined whether the fracture and osteoporosis<br />rates for patients in the ATAC trial treated with anastrozole suggest a protective effect of<br />tamoxifen, a specific effect of anastrozole, or both.<br />The incidence of osteoporosis was 10.5% in patients treated with anastrozole and 7.3%<br />in patients treated with tamoxifen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The experience of accidental overdose is limited.<br />In animal studies, anastrozole showed low acute toxicity.<br />Clinical trials have been conducted with various dosages of anastrozole, up to 60 mg in a<br />single dose given to healthy male volunteers and up to 10 mg daily given to postmenopausal<br />women with advanced breast cancer. These dosages were well tolerated. A single dose of<br />anastrozole that results in life-threatening symptoms has not been established.<br />As there is no specific antidote to overdose, treatment should be symptomatic.<br />In the management of an overdose, consideration should be given to the possibility that<br />multiple agents may have been taken. Vomiting may be induced if the patient is alert.<br />Dialysis may be of use as anastrozole does not bind strongly to proteins.<br />General supportive care, including frequent monitoring of vital signs and close observation<br />of the patient, is indicated</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Enzyme inhibitors. ATC code: L02B G03<br />Anastrazole is a potent, nonsteroidal, highly selective aromatase inhibitor. In postmenopausal<br />women, oestradiol is mainly produced by the conversion of androstenedione to oestrone<br />through the aromatase enzyme complex in peripheral tissues. Oestrone is subsequently<br />converted into oestradiol. It has been demonstrated that a reduction in circulating oestradiol<br />levels has a beneficial effect in women with breast cancer.<br />Using a highly sensitive method, a daily dose of 1 mg of anastrozole in postmenopausal<br />women suppressed oestroadiol by more than 80%.<br />Anastrozole has no progestogenic, androgenic or oestrogenic activity.<br />A daily dose of 10 mg of anastrozole has no effect on cortisol or aldosterone secretion, as<br />determined before or after standard ACTH stimulation testing. Cortocoid supplements are<br />therefore not required.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of anastrozole are age-independent in postmenopausal women.<br />Absorption<br />Anastrozole is absorbed rapidly, with peak plasma concentrations normally being reached<br />within two hours post-administration (under fasting conditions).<br />Food decreases the absorption rate slightly but not the degree of absorption. This minor<br />change in the absorption rate is not expected to have a clinically significant effect on the<br />steady-state plasma concentrations during daily treatment with 1 mg anastrozole tablets.<br />Steady-state anastrozole plasma concentrations of approximately 90&ndash;95% are achieved after 7<br />daily doses. There is no evidence that the pharmacokinetic parameters of anastrozole are<br />time-or dose-dependent.<br />Distribution<br />Only 40% of anastrozole is bound to plasma proteins.<br />Biotransformation<br />Postmenopausal women metabolise anastrozole extensively, with less than 10% of the dose<br />being excreted unaltered in urine during the 72 hours post-administration. Anastrozole<br />metabolism involves N-dealkylation, hydroxylation and glucuronidation. The metabolites are<br />mainly excreted in urine. Triazole, the main metabolite is plasma and urine, does not inhibit<br />aromatase.<br />Elimination<br />Anastrozole is eliminated slowly, with an elimination half-life in plasma of 40&ndash;50 hours.<br />The apparent clearance of anastrozole after oral administration in volunteers with stable<br />hepatic cirrhosis or renal impairment was in the range observed for healthy volunteers.<br />In males with pubertal gynaecomastia, anastrozole was rapidly absorbed, widely distributed<br />and eliminated slowly, with a half-life of approximately 2 days. Anastrozole clearance was<br />lower in girls than in these males, and exposure was greater. Anastrozole was widely<br />distributed and slowly eliminated in girls, with a half-life of approximately 0.8 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute toxicity: The mean lethal dose of anastrozole in acute toxicity studies in rodents was<br />greater than 100 mg/kg/day orally and 50 mg/kg/day intraperitoneally. The mean lethal dose<br />in an acute toxicity study in dog was greater than 45 mg/kg/day.<br />Chronic toxicity: Multiple dose toxicity studies were performed in rat and dog. No no-effect<br />levels were established for anastrozole in the toxicity studies, but those effects observed at the<br />low (1 mg/kg/day) and mid doses (dog 3 mg/kg/day; rat 5 mg/kg/day) were related to either<br />the pharmacological or enzyme-inducing properties of anastrozole and were not accompanied<br />by significant toxic or degenerative changes.<br />Mutagenicity: Genetic toxicology studies with anastrozole show that it is not mutagenic<br />or clastogenic.<br />Reproductive toxicology: In a fertility study, weanling male rats were dosed orally with 50<br />or 400 mg/L of anastrozole via their drinking water for 10 weeks. Measured mean plasma<br />concentrations were 44.4 (&plusmn;14.7) and 165 (&plusmn;90) ng/mL respectively. Mating indices were<br />adversely affected in both dose groups, although a reduction in fertility was evident only at the<br />400 mg/L dose level. This reduction was transient as all mating and fertility parameters were<br />similar to control group values following a nine-week treatment-free recovery period.<br />Oral administration of anastrozole to female rats produced a high incidence of infertility and<br />increased pre-implantation loss at a dose of 1 and 0.02 mg/kg/day, respectively. As these<br />effects occurred at clinically relevant doses, an effect in humans cannot be excluded.<br />These effects were related to the pharmacology of the compound and disappeared completely<br />after a five-week compound withdrawal period.<br />Oral administration of anastrozole to pregnant rats and rabbits caused no teratogenic effects at<br />doses up to 1.0 and 0.2 mg/kg/day, respectively. The effects observed (placental enlargement<br />in rats and pregnancy failure in rabbits) were related to the pharmacological activity of the<br />compound.<br />The survival of litters born to rats given anastrozole at a dose of 0.02 mg/kg/day and above<br />(from day 17 of pregnancy to day 22 post-partum) was compromised. These effects were<br />related to the pharmacological effects of the compound on parturition. There were no adverse<br />effects on the behaviour or reproductive performance of the first-generation offspring<br />attributable to maternal treatment with anastrozole.<br />Carcinogenicity: A two-year rat oncogenicity study resulted in an increase in incidence of<br />hepatic neoplasms and uterine stromal polyps in females and thyroid adenomas in males at<br />the high dose (25 mg/kg/day). These changes occurred at a dose which represents a 100-fold<br />greater exposure than occurs at human therapeutic doses and are considered not to be<br />clinically relevant to the treatment of patients with anastrozole.<br />A two-year mouse oncogenicity study resulted in the induction of benign ovarian tumours and<br />a disturbance in the incidence of lymphoreticular neoplasms (fewer histiocytic sarcomas in<br />females and more lymphoma-related deaths). These changes are considered to be mousespecific<br />effects of aromatase inhibition and not clinically relevant to the treatment of patients</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core:<br />Lactose monohydrate, anhydrous lactose, sodium carboxymethyl starch from potato,<br />microcrystalline cellulose (E460), anhydrous colloidal silica and magnesium stearate.<br />Tablet coating:<br />Hypromellose (E464), titanium dioxide (E171) and Macrogol 6000.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                30 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicine does not require any special storage conditions. Store in the original package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC/aluminium blisters<br />Packages containing 28 and 100 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br />Any unused medicinal product or waste material should be disposed of in accordance with<br />local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LABORATORIOS CINFA, S.A.
Olaz-Chipi, 10 – Polígono Areta
31620 Huarte-Pamplona (Navarre)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March-2011
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>